相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Lumacaftor-rescued F508del-CFTR has a modified bicarbonate permeability
Loretta Ferrera et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Small-molecule ion channels increase host defences in cystic fibrosis airway epithelia
Katrina A. Muraglia et al.
NATURE (2019)
Small molecule-facilitated anion transporters in cells for a novel therapeutic approach to cystic fibrosis
Michele Fiore et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Anion carriers as potential treatments for cystic fibrosis: transport in cystic fibrosis cells, and additivity to channel-targeting drugs
Hongyu Li et al.
CHEMICAL SCIENCE (2019)
Small molecule anionophores promote transmembrane anion permeation matching CFTR activity
Elsa Hernando et al.
SCIENTIFIC REPORTS (2018)
Anion-Transport Mechanism of a Triazole-Bearing Derivative of Prodigiosine: A Candidate for Cystic Fibrosis Therapy
Claudia Cossu et al.
FRONTIERS IN PHARMACOLOGY (2018)
In vitro Methods for the Development and Analysis of Human Primary Airway Epithelia
Ambra Gianotti et al.
FRONTIERS IN PHARMACOLOGY (2018)
Thymosin alpha-1 does not correct F508del-CFTR in cystic fibrosis airway epithelia
Valeria Tomati et al.
JCI INSIGHT (2018)
Role of CFTR in epithelial physiology
Vinciane Saint-Criq et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Cystic fibrosis: a clinical view
Carlo Castellani et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Cilia and Mucociliary Clearance
Ximena M. Bustamante-Marin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Where are we with transformational therapies for patients with cystic fibrosis?
Kris De Boeck et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Bypassing CFTR dysfunction in cystic fibrosis with alternative pathways for anion transport
Hongyu Li et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Anion transport and supramolecular medicinal chemistry
Philip A. Gale et al.
CHEMICAL SOCIETY REVIEWS (2017)
Efficient, non-toxic anion transport by synthetic carriers in cells and epithelia
Hongyu Li et al.
NATURE CHEMISTRY (2016)
Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets
Iram J. Haq et al.
THORAX (2016)
Acidic pH increases airway surface liquid viscosity in cystic fibrosis
Xiao Xiao Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Pharmacological rescue of mutant CFTR protein improves the viscoelastic properties of CF mucus
Ambra Gianotti et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Airway acidification initiates host defense abnormalities in cystic fibrosis mice
Viral S. Shah et al.
SCIENCE (2016)
CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
Miqueias Lopes-Pacheco
FRONTIERS IN PHARMACOLOGY (2016)
The innate immune function of airway epithelial cells in inflammatory lung disease
Pieter S. Hiemstra et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Preorganized Bis-Thioureas as Powerful Anion Carriers: Chloride Transport by Single Molecules in Large Unilamellar Vesicles
Hennie Valkenier et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis
Mark J. Hoegger et al.
SCIENCE (2014)
Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype
Jenny K. Gustafsson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Association of TMEM16A chloride channel overexpression with airway goblet cell metaplasia
Paolo Scudieri et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
J. P. Clancy et al.
THORAX (2012)
Ion Transport by Pulmonary Epithelia
Monika I. Hollenhorst et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Bonnie W. Ramsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Recent advances in the transmembrane transport of anions
Jeffery T. Davis et al.
CHEMICAL SOCIETY REVIEWS (2010)
Particle-Tracking Microrheology of Living Cells: Principles and Applications
Denis Wirtz
Annual Review of Biophysics (2009)
Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion
Mary Abigail S. Garcia et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Evidence for direct CFTR inhibition by CFTRinh-172 based on Arg347 mutagenesis
Emanuela Caci et al.
BIOCHEMICAL JOURNAL (2008)
Emerging drug treatments for cystic fibrosis
Pamela L. Zeitlin
EXPERT OPINION ON EMERGING DRUGS (2007)
Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium
RD Coakley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists
LVJ Galietta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
Green fluorescent protein-based halide indicators with improved chloride and iodide affinities
LJV Galietta et al.
FEBS LETTERS (2001)